Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Vaccines

Alternative players in US distribution gaining market share

The leading three animal health distributors in the US could be facing more of a challenge from smaller competitors as their market share dipped in the last year. 

Markets Equipment & Technology

Animal Pharm Podcast #10: Zoetis gives an insight into its external innovation strategy

In this latest podcast, Animal Pharm editor Joseph Harvey speaks to Scott Brown, vice president of external innovation at Zoetis. The podcast below covers the company's blueprint for external collaboration, particularly with human health businesses. 

Zoetis R&D

Zoetis outlines $54 million supply site expansion

Zoetis has confirmed its plans to expand its global manufacturing and supply facility in Charles City, Iowa. 

Zoetis Vaccines

VitamFero sets up master seed bank for toxoplasmosis vaccine

VitamFero has partnered with a fellow French company to establish a master seed bank for its Toxo KO ovine toxoplasmosis vaccine strain.

Europe France

Ceva debates its cutting edge poultry vaccines

Ceva Santé Animale is holding a US summit this week to present and discuss its new technology poultry vaccines and indicate further innovation it expects to see in the future.

North America United States

MERS vaccine research secures new Canadian funding

The search for a vaccine to prevent the deadly Middle East respiratory syndrome (MERS) has received a boost with the granting of new funding for the University of Saskatchewan in Canada.

Middle East and Africa Vaccines

AHI study details animal health's prominent contribution to the US economy

The US animal health industry is an "integral part of the US economy" worth around $9.9 billion in revenues, according to a new report from the Animal Health Institute (AHI).

United States Antiparasitics

ASU bags grant for efficacy trial of multivalent cancer vaccine for dogs

A researcher at Arizona State University (ASU) has been awarded $6.4 million to test a preventative canine cancer vaccine.

Vaccines Canine

EPRUMA highlights lack of One Health in vaccination initiative

The European Platform for the Responsible Use of Medicines in Animals (EPRUMA) has called for a One Health approach to vaccines in the EU.

Europe Policy & Regulation

Animal Pharm Podcast #9: Mark Heffernan explains Stonehaven Incubate's game plan

Stonehaven Incubate has been launched to translate innovation in the human health space into new animal health companies. Animal Pharm Joseph Harvey editor spoke to the firm's chief executive Mark Heffernan about this new home for start-ups. 

R&D Pharmaceuticals

FDA calls for comment on name guidance for veterinary medicines

The US FDA has issued draft guidance on proprietary names for new animal drugs.

North America United States

New body sets ambitious shrimp farming goals

A new Latin America-led body is aiming to improve shrimp farming by implementing higher standards, full traceability with zero use of antibiotics.

South America Ecuador
See All